Annual Working Capital
$244.89 M
+$52.54 M+27.32%
31 December 2023
Summary:
Olema Pharmaceuticals annual working capital is currently $244.89 million, with the most recent change of +$52.54 million (+27.32%) on 31 December 2023. During the last 3 years, it has fallen by -$36.77 million (-13.06%). OLMA annual working capital is now -27.45% below its all-time high of $337.55 million, reached on 31 December 2020.OLMA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$187.29 M
-$28.36 M-13.15%
30 September 2024
Summary:
Olema Pharmaceuticals quarterly working capital is currently $187.29 million, with the most recent change of -$28.36 million (-13.15%) on 30 September 2024. Over the past year, it has dropped by -$57.60 million (-23.52%). OLMA quarterly working capital is now -44.51% below its all-time high of $337.55 million, reached on 31 December 2020.OLMA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OLMA Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -23.5% |
| 3 y3 years | -13.1% | -33.5% |
| 5 y5 years | +10000.0% | +10000.0% |
OLMA Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -13.1% | +27.3% | -33.5% | +19.5% |
| 5 y | 5 years | -27.4% | >+9999.0% | -44.5% | >+9999.0% |
| alltime | all time | -27.4% | >+9999.0% | -44.5% | >+9999.0% |
Olema Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $187.29 M(-13.1%) |
| June 2024 | - | $215.65 M(-4.5%) |
| Mar 2024 | - | $225.87 M(-7.8%) |
| Dec 2023 | $244.89 M(+27.3%) | $244.89 M(-7.9%) |
| Sept 2023 | - | $266.04 M(+69.8%) |
| June 2023 | - | $156.68 M(-7.8%) |
| Mar 2023 | - | $169.99 M(-11.6%) |
| Dec 2022 | $192.35 M | $192.35 M(-9.5%) |
| Sept 2022 | - | $212.51 M(-7.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $230.72 M(-11.3%) |
| Mar 2022 | - | $260.05 M(-7.7%) |
| Dec 2021 | $281.67 M(-16.6%) | $281.67 M(-5.9%) |
| Sept 2021 | - | $299.38 M(-4.3%) |
| June 2021 | - | $312.71 M(-3.8%) |
| Mar 2021 | - | $324.99 M(-3.7%) |
| Dec 2020 | $337.55 M(<-9900.0%) | $337.55 M(+172.6%) |
| Sept 2020 | - | $123.81 M(-9810.9%) |
| Dec 2019 | -$1.27 M(-141.9%) | -$1.27 M |
| Dec 2018 | $3.04 M | - |
FAQ
- What is Olema Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Olema Pharmaceuticals?
- What is Olema Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Olema Pharmaceuticals?
- What is Olema Pharmaceuticals quarterly working capital year-on-year change?
What is Olema Pharmaceuticals annual working capital?
The current annual working capital of OLMA is $244.89 M
What is the all time high annual working capital for Olema Pharmaceuticals?
Olema Pharmaceuticals all-time high annual working capital is $337.55 M
What is Olema Pharmaceuticals quarterly working capital?
The current quarterly working capital of OLMA is $187.29 M
What is the all time high quarterly working capital for Olema Pharmaceuticals?
Olema Pharmaceuticals all-time high quarterly working capital is $337.55 M
What is Olema Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, OLMA quarterly working capital has changed by -$57.60 M (-23.52%)